Is a complete FRA/T5O research report available?

No complete published report is available for fra/T5O (FRA/T5O) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

FRA/T5O (FRA/T5O)

Frankfurt Stock Exchange: FRA/T5O · EUR

€0.83

+0.00 (0.0%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first FRA/T5O analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	225.6K
Revenue (ttm)	16.7K
Net income (ttm)	-365.4K
EPS (ttm)	-€1.34
Shares out	271.9K
Volume	0
Beta	4.99

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 16.7K
Net income (ttm): -365.4K
EPS (ttm): -€1.34
Market cap: 225.6K

All FRA/T5O indicators

Market & fundamental data

Available fields

157

Groups with data

Currency

EUR

Showing 157 of 157 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Germany
Country code	DE
Employees	2
Employees Change	1%
Employees Change Percent	100
Enterprise value	EUR 406,977
Exchange	Frankfurt Stock Exchange
Financial currency	EUR
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-07-31
Market cap	EUR 225,648
Price	EUR 0.83
Price currency	EUR
Rev Per Employee	8,365.5x
Sic	2836
Symbol	fra/T5O
Website	https://bioxxmed.ag

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-161.93%
EV/Sales	24.32x
FCF yield	-148.46%
P/B ratio	-225,648x
P/S ratio	13.49x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	100%
Gross Profit	EUR 16,731
Gross Profit Growth	378.99%
Gross Profit Growth3 Y	11%
Gross Profit Growth5 Y	-14.21%
Net Income	EUR -365,390
Pretax Margin	-2,184.46%
Profit Per Employee	EUR -182,695
ROA	-35.44
Roa5y	-28.08
ROCE	-57.92
ROE	-229.4
Roe5y	-139.6
ROIC	-48.18

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-46.29%
Cagr15y	-35.71%
Cagr1y	-59.54%
Cagr3y	-78.03%
Cagr5y	-73.36%
Revenue Growth	378.99x
Revenue Growth3 Y	11x
Revenue Growth5 Y	-14.21x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.03
Assets	EUR 469,112
Cash	EUR 203,668
Current Assets	EUR 309,109
Current Liabilities	EUR 868
Debt	EUR 385,000
Debt FCF	EUR -1.15
Equity	EUR -1
Interest Coverage	-34.94
Liabilities	EUR 469,112
Long Term Assets	EUR 160,003
Long Term Liabilities	EUR 468,244
Net Cash	EUR -181,332
Net Cash By Market Cap	EUR -80.36
Tangible Book Value	EUR -2
Tangible Book Value Per Share	EUR -0
WACC	12.72

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	356.1
Net Working Capital	EUR 104,573
Quick ratio	234.6
Working Capital	EUR 308,241
Working Capital Turnover	EUR 0.06

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-99.8%
1Y total return	-59.51%
200-day SMA	1.14
3Y total return	-98.94%
50-day SMA	0.99
50-day SMA vs 200-day SMA	50under200
5Y total return	-99.87%
All Time High	3,817.2
All Time High Change	-99.98%
All Time High Date	2014-10-10
All Time Low	0.01
All Time Low Change	16,500%
All Time Low Date	2025-11-19
ATR	0.02
Beta	4.99
Beta1y	0.87
Beta2y	0.24
Ch YTD	654.5
High	0.83
High52	2.75
High52 Date	2025-08-20
High52ch	-69.82%
Low	0.83
Low52	0.01
Low52 Date	2025-11-20
Low52ch	16,500%
Ma50ch	-15.93%
Price vs 200-day SMA	-27.19%
RSI	45.6
RSI Monthly	31.58
RSI Weekly	41.96
Sharpe ratio	1.73x
Sortino ratio	20.89
Tr YTD	654.5
Tr15y	-99.87%
Tr1m	3.75%
Tr1w	-0%
Tr3m	-8.29%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -271,228
Operating margin	-1,621.1

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Net Borrowing	385,000
Shares Out	271,865
Shares Qo Q	-0%
Shares Yo Y	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	111.8x
Bv Per Share	-0
Ch10y	-99.84
Ch15y	-99.89
Ch1m	3.75
Ch1w	-0
Ch1y	-59.51
Ch3m	-8.29
Ch3y	-99.13
Ch5y	-99.89
Ch6m	-36.15
Change	0%
Change From Open	0
Close	0.83
Days Gap	0
Depreciation Amortization	35
Earnings Date	2026-07-03
EBIT	EUR -271,228
EBITDA	EUR -271,193
EPS	EUR -1.34
F Score	3
FCF	EUR -335,000
FCF EV Yield	-82.31x
FCF Per Share	EUR -1.23
Financing CF	385,000
Fiscal Year End	December
Founded	2,000
Income Tax	EUR -92
Investing CF	-100,000
Is Primary Listing	1
Last Report Date	2025-12-31
Last Split Date	2026-01-14
Last Split Type	Reverse
Ma150	0.83
Ma150ch	-0.31%
Ma20	0.82
Ma20ch	1.74%
Net CF	-50,000
Open	0.83
Price Date	2026-07-30
Relative Volume	6.49x
Revenue	16,731x
Tax By Revenue	-0.55x
Tr6m	-36.15%
Volume	0
Z Score	-131.2

FRA/T5O (FRA/T5O)

Coverage state: Market snapshot only — no published research

Generate the first FRA/T5O analysis

Price

Financial snapshot

Fair-value bridge

Latest news · FRA/T5O

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All FRA/T5O indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on FRA/T5O

Frequently asked questions